FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering NIH News Releases

Trials failed to inform participants about the international transfer.Trials failed to inform participants about the international transfer. Read More NIH News Releases

Leave a Comment

Your email address will not be published. Required fields are marked *